
NVS
Healthcare · Drug Manufacturers - General · $303.12B market cap
$160.50+0.25 (+0.2%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +6.1% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 27, 2026 | Before the open | 2.25 | 2.46 | +9.3% |
| Jul 21, 2026 | Before the open | 2.20 | 2.41 | +9.5% |
| Apr 27, 2026 | After the close | 1.65 | 1.65 | 0.0% |
| Feb 4, 2026 | Before the open | 2.00 | 2.03 | +1.5% |
| Oct 28, 2025 | Before the open | 2.31 | 2.25 | -2.6% |
| Jul 17, 2025 | Before the open | 2.37 | 2.42 | +2.1% |
| Apr 29, 2025 | Before the open | 2.17 | 2.28 | +5.1% |
| Jan 30, 2025 | After the close | 1.76 | 1.98 | +12.5% |
| Oct 28, 2024 | After the close | 1.93 | 2.06 | +6.7% |
| Jul 17, 2024 | After the close | 1.86 | 1.97 | +5.9% |
| Apr 22, 2024 | After the close | 1.68 | 1.80 | +7.1% |
| Jan 30, 2024 | After the close | 1.66 | 1.53 | -7.8% |
| Oct 24, 2023 | Before the open | 1.74 | 1.74 | 0.0% |
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure; Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin…
| Jul 17, 2023 | After the close | 1.76 | 1.83 | +4.0% |
| Apr 25, 2023 | Before the open | 1.53 | 1.71 | +11.8% |
| Jan 31, 2023 | After the close | 1.43 | 1.52 | +6.3% |
| Oct 25, 2022 | Before the open | 1.62 | 1.58 | -2.5% |
| Jul 19, 2022 | Before the open | 1.54 | 1.56 | +1.3% |
| Apr 26, 2022 | Before the open | 1.51 | 1.46 | -3.3% |
| Feb 2, 2022 | Before the open | 1.41 | 1.40 | -0.7% |
| Oct 26, 2021 | Before the open | 1.66 | 1.71 | +3.0% |
| Jul 21, 2021 | Before the open | 1.49 | 1.66 | +11.4% |
| Apr 27, 2021 | Before the open | 1.62 | 1.52 | -6.2% |
| Jan 25, 2021 | After the close | 1.39 | 1.34 | -3.6% |
| Oct 27, 2020 | Before the open | 1.45 | 1.52 | +4.8% |
| Jul 21, 2020 | Before the open | 1.33 | 1.36 | +2.3% |
| Apr 28, 2020 | Before the open | 1.36 | 1.56 | +14.7% |
| Jan 28, 2020 | After the close | 1.31 | 1.32 | +0.8% |
| Oct 22, 2019 | Before the open | 1.35 | 1.41 | +4.4% |
| Jul 18, 2019 | Before the open | 1.23 | 1.34 | +8.9% |
| Apr 24, 2019 | After the close | 1.21 | 1.21 | 0.0% |
| Jan 30, 2019 | Before the open | 1.30 | 1.25 | -3.8% |
| Oct 18, 2018 | Before the open | 1.34 | 1.32 | -1.5% |
| Jul 18, 2018 | Before the open | 1.28 | 1.29 | +0.8% |
| Apr 19, 2018 | Before the open | 1.27 | 1.28 | +0.8% |
| Jan 24, 2018 | Before the open | 1.17 | 1.21 | +3.4% |